A SBIR Phase II contract was awarded to Arzeda in August, 2022 for $1,118,433.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
Currently, there are no issues on this topic.